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Aims: An increase in intracellular vascular smoothmuscle cell calcium concentration (VSMC [Ca2+]i) is essential for
endothelin-1 (ET-1)-induced vasoconstriction. Based on previous ﬁndings that activation of the G protein-coupled
estrogen receptor (GPER) inhibits vasoconstriction in response to ET-1 and regulates [Ca2+]i in cultured VSMC, we
investigated whether endogenous GPER regulates ET-1-induced changes in VSMC [Ca2+]i and constriction of intact
arteries.
Main methods: Pressurized carotid arteries of GPER-deﬁcient (GPER0) and wildtype (WT) mice were loaded with
the calcium indicator fura 2-AM. Arteries were stimulated with the GPER-selective agonist G-1 or solvent followed
by exposure to ET-1. Changes in arterial diameter and VSMC [Ca2+]i were recorded simultaneously. Vascular gene
expression levels of ETA and ETB receptors were determined by qPCR.
Key ﬁndings: ET-1-dependent vasoconstrictionwas increased in arteries fromGPER0 compared to arteries fromWT
mice. Despite the more potent vasoconstriction to ET-1, GPER deﬁciency was associated with a marked reduction
in the ET-1-stimulated VSMC [Ca2+]i increase, suggesting an increase in myoﬁlament force sensitivity to [Ca
2+]i.
Activation of GPER by G-1 had no effect on vasoconstriction or VSMC [Ca2+]i responses to ET-1, and expression
levels of ETA or ETB receptor were unaffected by GPER deﬁciency.
Signiﬁcance: These results demonstrate that endogenous GPER inhibits ET-1-induced vasoconstriction, an effect
that may be associated with reduced VSMC Ca2+ sensitivity. This represents a potential mechanism through
which GPER could contribute to protective effects of endogenous estrogen in the cardiovascular system.© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Endothelin-1 (ET-1) is the most potent endogenous vasoconstrictor
known (Yanagisawa et al., 1988) that regulates basal vascular tone, and
contributes to the development of vascular diseases, such as arterial hy-
pertension and atherosclerosis through stimulation of cell growth and
inﬂammation (Barton and Yanagisawa, 2008). ET-1 is the predominant
isoformof the endothelin peptide family, which acts in an autocrine and
paracrine manner via G protein-coupled endothelin receptors ETA and
ETB (Barton and Yanagisawa, 2008; Wynne et al., 2009). Whereas ETA
receptors mediate vasoconstriction and cell proliferation, ETB receptors
primarily facilitate the release of nitric oxide and ET-1 clearance (Barton
and Yanagisawa, 2008; Wynne et al., 2009). In vascular smooth muscle
cells (VSMC), ETA receptor activation by ET-1 induces an increase in in-
tracellular VSMC calcium concentration (VSMC [Ca2+]i), which is theby Dr. David M. Pollock, Guest
viewers and ﬁnal decision.
y and Physiology, University of
131, United States. Tel.: +1 505
ssnitz).
-NC-ND license.intracellular messenger that triggers subsequent vasoconstriction
(Wynne et al., 2009; Miwa et al., 2005).
Natural estrogens, such as 17β-estradiol, have been implicated in pro-
tection from cardiovascular diseases, including arterial hypertension and
atherosclerosis (Meyer et al., 2006; Barton and Meyer, 2009). 17β-
Estradiol inhibits ET-1-dependent vasoconstriction in several vascular
beds (Jiang et al., 1992; Lamping and Nuno, 1996; Sudhir et al., 1997a;
Teoh et al., 2000; Tsang et al., 2004a), possibly via inhibition of Ca2+ in-
ﬂux and/or stimulation of Ca2+efﬂux inVSMC (Jiang et al., 1992; Prakash
et al., 1999). 17β-Estradiol is a non-selective activator of estrogen recep-
tors ERα and ERβ, which mainly function as ligand-activated transcrip-
tion factors (Prossnitz and Barton, 2011). More recently, 17β-estradiol
has also been shown to bind to and activate the G protein-coupled estro-
gen receptor GPER (previously termed GPR30), an intracellular seven-
transmembrane spanning receptor (Revankar et al., 2005). GPER is
expressed throughout the vascular system of humans and animals of
both sexes (Prossnitz and Barton, 2011; Meyer et al., 2011), and animals
lacking the GPER gene display increased endothelium-dependent con-
tractility (Meyer et al., 2012). Moreover, the GPER-selective agonist G-1
(Bologa et al., 2006) induces acute vasodilation and indirectly inhibits
the response to several vasoconstrictors including ET-1 (Prossnitz and
Barton, 2011; Meyer et al., 2010; 2011; Haas et al., 2009; Broughton
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modulators (SERMs) including raloxifene, the selective estrogen receptor
downregulator (SERD) fulvestrant, or the phytoestrogen genistein also
inhibit vasoconstriction to ET-1 (Prossnitz and Barton, 2011; Meyer
et al., 2010, 2011; Tsang et al., 2004b; Lee et al., 2004). Although selective
GPER activation regulates [Ca2+]i in VSMC cells (Haas et al., 2009) and
other cell types (Prossnitz and Barton, 2011), it is unknown whether
and to what extent endogenous GPER modulates the VSMC [Ca2+]i re-
sponse to vasoconstrictors such as ET-1 in intact arteries.
To test the hypothesis that endogenous GPER inhibits ET-1-
induced arterial constriction by regulating changes in VSMC [Ca2+]i,
we simultaneously measured changes in vascular tone and VSMC
[Ca2+]i in response to ET-1 in arteries from wildtype (WT) and
GPER-deﬁcient (GPER0) mice. In addition, we determined the acute
effects of selective GPER activation by G-1 on vascular responses.
Materials and methods
Materials
Fura 2-AM (fura 2-acetoxymethyl ester) and pluronic acid were from
Invitrogen (Carlsbad, CA, USA), and ET-1 was from Enzo Life Sciences
(Farmingdale, NY, USA). G-1 was synthesized as described (Bologa et al.,
2006) (provided by Jeffery Arterburn, New Mexico State University, Las
Cruces, NM, USA), and dissolved in ethanol. G-1 and ET-1 were diluted
in bicarbonate buffered physiological saline solution (PSS, composition
in mmol/L: 129.8 NaCl, 5.4 KCl, 0.83 MgSO4, 0.43 NaH2PO4, 19 NaHCO3,
1.8 CaCl2, and 5.5 glucose) to the concentrations required before use.
Animals
Male C57Bl6 (3 months of age, The Jackson Laboratory, Bar Harbor,
ME) and GPER0 mice (Proctor & Gamble, Cincinnati, OH, provided by
Jan S. Rosenbaum) were housed at the animal research facility of the
University of New Mexico Health Sciences Center. GPER0 mice were
bred as described (Wang et al., 2008) and backcrossed 10 generations
onto C57Bl6 mice. Animals were maintained under controlled temper-
ature of 22–23 °C on a 12 h light, 12 h dark cycle and fed normal
chowad libitum. All procedureswere approved by and carried out in ac-
cordancewith institutional policies and theNational Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Isolated vessel preparation and experimental setup
Animals were anesthetized by intraperitoneal injection of sodium
pentobarbital (2.2 mg/g BW) and exsanguinated by cardiac puncture.
Common carotid arteries were excised, immediately placed into ice-
cold PSS and carefully dissected from adherent tissue. A subset of carot-
id arterieswas snap-frozen in liquid nitrogen and stored at−80 °C until
further analysis. For functional experiments, carotid arterieswere trans-
ferred to a vessel chamber (Living Systems, St. Albans, VT, USA), cannu-
lated on glassmicropipettes at each end, and securedwith silk ligatures.
Arteries were pressurized to 90 mm Hg with PSS using a servo-
controlled peristaltic pump (Living Systems), and superfused with PSS
(37 °C, pH 7.4, oxygenated with 21% O2, 5% CO2, and balanced N2) at a
rate of 5 mL per minute as described (Allahdadi et al., 2008). To avoid
ﬂow-dependent changes in vessel diameter, experiments were per-
formed with the distal cannula closed. Arterial segments that did not
maintain pressure were discarded.
Measurement of carotid artery VSMC [Ca2+]i and constriction
Following a 30 min equilibration period, pressurized arteries were
incubated for 45 min with 2 μmol/L fura 2-AM and 0.05% pluronic acid
in 4 mL HEPES-PSS (composition in mmol/L: 134 NaCl, 6 KCl, 1 MgCl2,
10 HEPES, 2 CaCl2, 0.026 EDTA, and 10 glucose; pH 7.4) in the dark atroom temperature (Allahdadi et al., 2008). After incubation, arteries
were washedwith oxygenated PSS (37 °C) for 15 min to remove excess
dye. Arteries were then stimulated with the GPER-selective agonist G-1
(3 μmol/L) (Bologa et al., 2006) or solvent (ethanol 0.1% vol/vol) for
20 min as described (Haas et al., 2009;Meyer et al., 2010), followedby ex-
posure to ET-1 (10 nmol/L) as the constricting agonist. Some arteries
were subsequently incubated in Ca2+ free PSS to determine maximal di-
ameter, which did not differ from inner diameter before stimulationwith
ET-1 (data not shown). Fura 2-AM-loaded vessels were alternately excit-
ed at 340 nm and 380 nm at a frequency of 1 Hz with a HyperSwitch
dual-excitation light source (IonOptix, Milton, MA, USA), and the respec-
tive 510 nm emissions collected with a photomultiplier tube (F340/F380).
Background-subtracted F340/F380 emission ratios as a measure of relative
VSMC [Ca2+]i and inner arterial diameter from bright-ﬁeld images were
continuously calculated with IonWizard software (Version 5.0, IonOptix)
as described (Allahdadi et al., 2008). Vasoconstriction was calculated as
percent reduction of the maximal internal arterial diameter.
Quantitative real-time polymerase chain reaction (qPCR)
Frozen carotid arteries were disrupted and homogenized using a
rotor-stator homogenizer, and total RNA was extracted using the
silica-based RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA,
USA). RNA was reverse transcribed with High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Carlsbad, CA, USA). qPCR was
performed using TaqMan gene expression assays on a 7500 FAST
real-time PCR System (Applied Biosystems). The following sets of
primers were used: 5′-GAAGGACTGGTGGCTCTTTG-3′ (forward) and
5′-CTTCTCGACGCTGTTTGAGG-3′ (reverse) for ampliﬁcation of a spe-
ciﬁc cDNA fragment encoding for murine ETA receptor (GenBank ID:
BC008277); 5′-CGGTATGCAGATTGCTTTGA-3′ (forward) and 5′-
CACCTGTGTGGATTGCTCTG-3′ (reverse) for ampliﬁcation of a speciﬁc
cDNA fragment encoding for murine ETB receptor (GenBank ID:
BC026553); 5′-TTCACCACCATGGAGAAGGC-3′ (forward) and 5′-
GGCATGGACTGTGGTCATGA-3′ (reverse) for ampliﬁcation of a speciﬁc
cDNA fragment encoding for murine GAPDH (GenBank ID:
NM_008084), which served as house-keeping control. Gene expression
was calculated using the 2−ΔΔCT method (Livak and Schmittgen, 2001).
Statistical analyses
Data was analyzed using the Student's t-test or two-way repeated-
measures ANOVA followed by Bonferroni post hoc analysis where ap-
propriate (Prism version 5.0 for Macintosh, GraphPad Software, San
Diego, CA, USA). Values are shown as mean±SEM of independent ex-
periments. A Pb0.05 value was considered statistically signiﬁcant.
Results
Effect of GPER deﬁciency on ET-1-induced vasoconstriction
The vasoconstrictor response to ET-1 was signiﬁcantly greater in
arteries from GPER0 mice (31.8±1.5% vs. 24.0±2.9%, n=5, Pb0.05
vs. WT; Figs. 1 and 2). However, the kinetics of vasoconstriction, mea-
sured as the time to maximal constriction, were delayed by approxi-
mately 90 s in GPER0 arteries (506±26 vs. 413±22 s, n=5, Pb0.03
vs. WT; Fig. 2C). Acute selective GPER activation by G-1 had no effect
on ET-1-induced vasoconstriction (26.7±1.6% vs. 24.0±2.9%,
n=5–7, P=n.s. vs. solvent).
GPER-dependent regulation of ET-1-stimulated VSMC [Ca2+]i increase
Despite the greater vasoconstrictor response to ET-1, GPER deﬁ-
ciency was associated with a 40% reduction in the ET-1-stimulated
VSMC [Ca2+]i increase (0.097±0.015 vs. 0.162±0.018, n=7–8,
Pb0.02 vs. WT; Figs. 1 and 3A). Steady-state VSMC [Ca2+]i did not
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Fig. 1. Original recordings of vasoconstrictor responses (measured as change in arterial diameter, top) and VSMC [Ca2+]i (given as relative F340/F380 ratio, bottom) of carotid arteries
from WT and GPER0 mice following exposure to endothelin-1 (10 nmol/L, arrows). Changes in arterial diameter and VSMC [Ca2+]i were recorded simultaneously.
625M.R. Meyer et al. / Life Sciences 91 (2012) 623–627differ between WT and GPER0 mice (0.579±0.012 vs. 0.561±0.008,
n=7–8, P=n.s., Fig. 3A). Moreover, acute selective GPER activation
by G-1 had no effect on the calcium response evoked by ET-1 in WT
arteries (0.749±0.039 vs. 0.740±0.021, n=7, P=n.s. vs. solvent,
Fig. 3A). In addition to the overall inhibition of ET-1-stimulated
VSMC [Ca2+]i, time-dependent VSMC [Ca2+]i responses were
delayed 1.4-fold in GPER0 arteries independent of treatment with G-
1 or solvent (66.7±6.8 vs. 48.6±2.4 s for maximal VSMC [Ca2+]i in-
crease, n=14, Pb0.02 vs. WT; Fig. 3B).
Effect of GPER deﬁciency on endothelin receptor expression
In view of the greater vasoconstrictor response to ET-1 in GPER
deﬁcient animals, we evaluated steady-state ETA and ETB receptor
mRNA expression levels in carotid arteries of WT and GPER0 mice.
GPER deﬁciency affected neither vascular gene expression of ETA re-
ceptor nor ETB receptor (Table 1), indicating that the more potent re-
sponse to ET-1 in GPER0 mice is not due to changes in receptor
expression levels. Moreover, vascular gene expression levels of ETA
receptor were 5.7-fold higher than ETB receptor in arteries of both
WT and GPER0 mice (P≤0.001; Table 1).
Discussion
This study has identiﬁed endogenous GPER as a regulator of ET-1-
induced vasoconstriction and the associated changes in VSMC [Ca2+]i
in intact arteries. GPER deﬁciency results in increased contractility
despite a pronounced reduction in ET-1-stimulated VSMC [Ca2+]i,
suggesting an increase in myoﬁlament force sensitivity to [Ca2+]i in
arteries lacking GPER.
We have previously reported that the GPER agonists G-1 and ICI
182,780 acutely inhibit isometric contractions to ET-1 inporcine coronary
arteries (Meyer et al., 2010). The present study extends these ﬁndings
showing that in murine carotid arteries, the presence of endogenous
GPER is sufﬁcient to inhibit vasoconstriction to ET-1 without affecting
ETA or ETB receptor gene expression levels. Similarly, we recently
reported that GPER deletion increases endothelium-dependent contrac-
tility (Meyer et al., 2012). In carotid arteries used in the present study,the GPER-selective agonist G-1 had no acute effect on ET-1-induced con-
striction, indicating differential effects of chronic basal activity and acute
activation of GPER. Moreover, differences in responsiveness to G-1 be-
tween species and vascular beds may explain its varied effects on ET-1-
induced contraction in murine carotid and porcine coronary arteries
(Meyer et al., 2010). Similarly, while estrogen acutely inhibits vasocon-
striction to ET-1 in several vascular beds of different species (Jiang et al.,
1992; Lamping and Nuno, 1996; Sudhir et al., 1997a; Teoh et al., 2000),
this effect might not apply to all arteries (Haas et al., 2007).
We have previously shown in isolated VSMC that direct adminis-
tration of the GPER-selective agonist G-1 acutely increases [Ca2+]i,
while pretreatment with G-1 inhibits serotonin-mediated Ca2+ in-
creases (Haas et al., 2009). Moreover, it has been demonstrated that
the non-selective ER agonist 17β-estradiol acutely inhibits ET-1-
stimulated [Ca2+]i increases in coronary artery VSMC from female
pigs by stimulating Ca2+ efﬂux (Prakash et al., 1999). The present
study now demonstrates that GPER modulates ET-1-stimulated
VSMC [Ca2+]i in intact arteries providing further evidence that en-
dogenous GPER is speciﬁcally involved in the regulation of VSMC
[Ca2+]i and the subsequent constrictor response to ET-1.
Ca2+ is a principal intracellular messenger that triggers cross-
bridge cycling between actin ﬁlaments and myosin resulting in
VSMC contraction (Jackson, 2000). However, vasoconstrictors such
as ET-1 may increase myosin regulatory light chain (MLC) phosphor-
ylation and VSMC force under certain conditions while [Ca2+]i is
clamped, a phenomenon referred to as Ca2+ sensitization (Wynne
et al., 2009; Somlyo and Somlyo, 2003). Our observation that GPER
deﬁciency is associated with greater ET-1-induced vasoconstriction
despite a markedly reduced increase in VSMC [Ca2+]i suggests an in-
crease in myoﬁlament force sensitivity to even low levels of [Ca2+]i.
Interestingly, the lack of GPER considerably delayed the contractile
response to ET-1, which could reﬂect the time required for activation
of pathways involved in regulating MLC phosphorylation (Somlyo
and Somlyo, 2003). Endogenous estrogens have previously been im-
plicated in reducing the sensitivity of contractile proteins to Ca2+:
In basilar arteries of male and ovariectomized female rats, reducing
MLC phosphorylation by inhibition of Rho-associated kinase (ROK)
results in a stronger dilator response compared to females with intact
Fig. 2. Endothelin-1-induced constriction in carotid arteries of WT and GPER0 mice.
Time-dependent vasoconstriction to endothelin-1 (10 nmol/L, A), maximal responses
(B), and time until maximal constriction (C) are shown. Vasoconstriction was calculated
as the percent reduction of the maximal internal arterial diameter. Values are means±
SEM; n=5. *Pb0.05 vs. WT.
Table 1
Gene expression levels of ETA and ETB receptors in carotid arteries of WT and GPER0
mice. Values are calculated using the 2−ΔΔCT method (Livak and Schmittgen, 2001)
and expressed as arbitrary units (mean±SEM); n=5–6.
Gene WT GPER0
ETA receptor 304±54 336±18
ETB receptor 53±9⁎ 59±13⁎
⁎ Pb0.001 vs. ETA receptor.
626 M.R. Meyer et al. / Life Sciences 91 (2012) 623–627ovaries or receiving 17β-estradiol replacement (Chrissobolis et al.,
2004). Moreover, greater serotonin-dependent contractions in aorta
from male compared to female mice are abolished after ROK inhibi-
tion (Nuno et al., 2007). Based on the recognition of GPER as a poten-
tial mediator of the Ca2+ desensitizing effects of estrogens, future
studies should address whether and through which mechanisms
GPER regulates MLC phosphorylation independent of changes in
VSMC [Ca2+]i.
The present study was performed in arteries frommale mice, indi-
cating that GPER, a receptor for a hormone traditionally implicated inFig. 3. Changes inVSMC [Ca2+]i (A) and time tomaximal VSMC [Ca2+]i increase (B) in response
with the GPER-selective agonist G-1 (3 μmol/L) or solvent (ethanol, EtOH 0.1% vol/vol) for 20female biology, also affects the male vasculature. Indeed, GPER is
expressed in the cardiovascular system of both females and males
(Prossnitz and Barton, 2011; Meyer et al., 2011), with GPER-
mediated acute relaxation of carotid arteries observed in male ro-
dents (Haas et al., 2009; Broughton et al., 2010). However, basal in-
trinsic activity of GPER in the absence of a ligand, which has been
observed for many other G protein-coupled receptors (Gilchrist and
Blackmer, 2007), may be sufﬁcient to mediate vascular effects. Fur-
thermore, local conversion from androgen precursors into estrogens
by the enzyme aromatase within the vascular wall could yield sufﬁ-
cient tissue concentrations to mediate relevant physiological effects
(Prossnitz and Barton, 2011; Meyer et al., 2011). In addition, genetic
deletion of the classical ERα and ERβ has adverse effects on vascular
tone in males (Rubanyi et al., 1997; Sudhir et al., 1997b; Zhu et al.,
2002). Taken together, these ﬁndings indicate a role for multiple es-
trogen receptors in male vascular physiology. Nevertheless, future
studies should address potential sex differences in GPER-dependent
regulation of ET-1-induced VSMC [Ca2+]i and vasoconstriction.
Conclusions
GPER-mediated inhibition of the ET-1-stimulated VSMC [Ca2+]i in-
creases represents a newly identiﬁed mechanism that may mediate
the observed inhibition of ET-1-dependent vasoconstriction. Tonic inhi-
bition of ET-1-induced vasoconstriction by endogenous GPER may con-
tribute to the protective effects of estrogens or other GPER agonists such
as SERMs (Prossnitz and Barton, 2011; Meyer et al., 2011) in the patho-
genesis of cardiovascular diseases (Meyer et al., 2006; Barton and
Meyer, 2009).
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